{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:48:09Z","timestamp":1790750889712,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":346,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.7861\/clinmed.2022-0415","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T16:30:13Z","timestamp":1684341013000},"page":"206-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis"],"prefix":"10.1016","volume":"23","author":[{"given":"Sonja C Mansfield","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa R","family":"Al-Hashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan B","family":"Mukhtyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2022-0415_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","article-title":"Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study","volume":"19","author":"Brekke","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.7861\/clinmed.2022-0415_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2022-0415_bib3","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00417-016-3434-7","article-title":"Giant cell arteritis: ophthalmic manifestations of a systemic disease","volume":"254","author":"De Smit","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.7861\/clinmed.2022-0415_bib4","first-page":"291","article-title":"Posterior ciliary arterial occlusive disorders","volume":"91","author":"Hayreh","year":"1971","journal-title":"Trans Ophthalmol Soc UK (1962)"},{"key":"10.7861\/clinmed.2022-0415_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0954-6820.1977.tb15683.x","article-title":"Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients","volume":"201","author":"Sorensen","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.7861\/clinmed.2022-0415_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/003693307902400203","article-title":"Temporal arteritis. A 14-year epidemiological, clinical and prognostic study","volume":"24","author":"Jonasson","year":"1979","journal-title":"Scott Med J"},{"key":"10.7861\/clinmed.2022-0415_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","article-title":"Prognosis in giant-cell arteritis","volume":"282","author":"Graham","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.7861\/clinmed.2022-0415_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.1780240706","article-title":"The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications","volume":"24","author":"Bengtsson","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2022-0415_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"10.7861\/clinmed.2022-0415_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/112067219700700412","article-title":"Neuro-ophthalmic complications of biopsy-proven giant cell arteritis","volume":"7","author":"Glutz von Blotzheim","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"10.7861\/clinmed.2022-0415_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2022-0415_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.7861\/clinmed.2022-0415_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.7861\/clinmed.2022-0415_bib14","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.7861\/clinmed.2021-0126","article-title":"Improving the quality of care for people with giant cell arteritis","volume":"21","author":"Mukhtyar","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.7861\/clinmed.2022-0415_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10067-019-04772-2","article-title":"Validating a diagnostic GCA ultrasonography service against temporal artery biopsy and long-term clinical outcomes","volume":"39","author":"Mukhtyar","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2022-0415_bib17","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/rmdopen-2017-000598","article-title":"Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group","volume":"4","author":"Chrysidis","year":"2018","journal-title":"RMD Open"},{"key":"10.7861\/clinmed.2022-0415_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/rheumatology\/kez548","article-title":"The need to establish standards of care for Giant Cell Arteritis","volume":"59","author":"Mukhtyar","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2022-0415_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/annrheumdis-2018-214755","article-title":"2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis","volume":"78","author":"Ehlers","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2022-0415_bib20","first-page":"524","article-title":"The association of vascular risk factors with visual loss in giant cell arteritis","volume":"56","author":"Yates","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2022-0415_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3899\/jrheum.171428","article-title":"Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises","volume":"45","author":"Schafer","year":"2018","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.semarthrit.2021.04.014","article-title":"OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis","volume":"51","author":"Schafer","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmed.2022-0415_bib23","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1007\/s00330-020-07595-x","article-title":"High-resolution MRI demonstrates signal abnormalities of the 3rd cranial nerve in giant cell arteritis patients with 3rd cranial nerve impairment","volume":"31","author":"Mournet","year":"2021","journal-title":"Eur Radiol"},{"key":"10.7861\/clinmed.2022-0415_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.7861\/clinmed.2022-0415_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib26","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1097\/MD.0000000000003210","article-title":"Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study","volume":"95","author":"Hocevar","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.7861\/clinmed.2022-0415_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.7861\/clinmed.2022-0415_bib28","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s10067-021-05643-5","article-title":"Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis","volume":"40","author":"Baalbaki","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/eye.1996.101","article-title":"Colour Doppler imaging in giant cell (temporal) arteritis: serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy","volume":"10","author":"Ghanchi","year":"1996","journal-title":"Eye (Lond)"},{"key":"10.7861\/clinmed.2022-0415_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.7861\/clinmed.2022-0415_bib31","doi-asserted-by":"crossref","first-page":"120222","DOI":"10.1016\/j.jns.2022.120222","article-title":"Ischemic ocular manifestations of giant cell arteritis: A Canadian case series","volume":"436","author":"Issa","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.7861\/clinmed.2022-0415_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3899\/jrheum.151135","article-title":"Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients","volume":"43","author":"Liozon","year":"2016","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib33","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.7861\/clinmed.2022-0415_bib34","first-page":"S103","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.7861\/clinmed.2022-0415_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2022-0415_bib36","first-page":"401","article-title":"Middle meningeal origin of the ophthalmic artery","volume":"49","author":"Liu","year":"2001","journal-title":"Neurosurgery"},{"key":"10.7861\/clinmed.2022-0415_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2022-0415_bib38","doi-asserted-by":"crossref","first-page":"rkz001","DOI":"10.1093\/rap\/rkz001","article-title":"Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen","volume":"3","author":"Mukhtyar","year":"2019","journal-title":"Rheumatol Adv Pract"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2022-0415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:50:49Z","timestamp":1744447849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824046025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1470211824046025"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2022-0415","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2022-0415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2023. All rights reserved.","name":"copyright","label":"Copyright"}]}}